Transcriptional Repression of C-Myb and GATA-2 is Involved in the Biologic Effects of C/EBPalpha in P210BCR/ABL-expressing Cells

Overview

Journal Blood

Publisher Elsevier

Specialty Hematology

Date 2008 Jun 14

PMID 18550858

Citations 9

Authors

Angela Rachele Soliera

Maria Rosa Lidonnici

Giovanna Ferrari-Amorotti

Marco Prisco

Ying Zhang

Robert V Martinez

Nick J Donato

Bruno Calabretta

Affiliations

Soon will be listed here.

Abstract

Ectopic C/EBPalpha expression in p210(BCR/ABL)-expressing hematopoietic cells induces granulocytic differentiation, inhibits proliferation, and suppresses leukemogenesis. To assess the underlying mechanisms, C/EBPalpha targets were identified by microarray analyses. Upon C/EBPalpha activation, expression of c-Myb and GATA-2 was repressed in 32D-BCR/ABL, K562, and chronic myelogenous leukemia (CML) blast crisis (BC) primary cells but only c-Myb levels decreased slightly in CD34(+) normal progenitors. The role of these 2 genes for the effects of C/EBPalpha was assessed by perturbing their expression in K562 cells. Ectopic c-Myb expression blocked the proliferation inhibition- and differentiation-inducing effects of C/EBPalpha, whereas c-Myb siRNA treatment enhanced C/EBPalpha-mediated proliferation inhibition and induced changes in gene expression indicative of monocytic differentiation. Ectopic GATA-2 expression suppressed the proliferation inhibitory effect of C/EBPalpha but blocked in part the effect on differentiation; GATA-2 siRNA treatment had no effects on C/EBPalpha induction of differentiation but inhibited proliferation of K562 cells, alone or upon C/EBPalpha activation. In summary, the effects of C/EBPalpha in p210(BCR/ABL)-expressing cells depend, in part, on transcriptional repression of c-Myb and GATA-2. Since perturbation of c-Myb and GATA-2 expression has nonidentical consequences for proliferation and differentiation of K562 cells, the effects of C/EBPalpha appear to involve dif-ferent transcription-regulated targets.

Citing Articles

Targeting the CDK6 Dependence of Ph+ Acute Lymphoblastic Leukemia.

Porazzi P, De Dominici M, Salvino J, Calabretta B Genes (Basel). 2021; 12(9).

PMID: 34573335 PMC: 8467343. DOI: 10.3390/genes12091355.

Transcriptional activation of the miR-17-92 cluster is involved in the growth-promoting effects of MYB in human Ph-positive leukemia cells.

Spagnuolo M, Regazzo G, De Dominici M, Sacconi A, Pelosi A, Korita E Haematologica. 2018; 104(1):82-92.

PMID: 30076175 PMC: 6312025. DOI: 10.3324/haematol.2018.191213.

Targeting CDK6 and BCL2 Exploits the "MYB Addiction" of Ph Acute Lymphoblastic Leukemia.

De Dominici M, Porazzi P, Soliera A, Mariani S, Addya S, Fortina P Cancer Res. 2017; 78(4):1097-1109.

PMID: 29233926 PMC: 5815914. DOI: 10.1158/0008-5472.CAN-17-2644.

Targeting acute myeloid leukemia by drug-induced c-MYB degradation.

Walf-Vorderwulbecke V, Pearce K, Brooks T, Hubank M, van den Heuvel-Eibrink M, Zwaan C Leukemia. 2017; 32(4):882-889.

PMID: 29089643 DOI: 10.1038/leu.2017.317.

GATA2 regulates dendritic cell differentiation.

Onodera K, Fujiwara T, Onishi Y, Itoh-Nakadai A, Okitsu Y, Fukuhara N Blood. 2016; 128(4):508-18.

PMID: 27259979 PMC: 5026465. DOI: 10.1182/blood-2016-02-698118.

References

Johansen L, Iwama A, Lodie T, Sasaki K, Felsher D, Golub T . c-Myc is a critical target for c/EBPalpha in granulopoiesis. Mol Cell Biol. 2001; 21(11):3789-806. PMC: 87031. DOI: 10.1128/MCB.21.11.3789-3806.2001. View

DAlo F, Johansen L, Nelson E, Radomska H, Evans E, Zhang P . The amino terminal and E2F interaction domains are critical for C/EBP alpha-mediated induction of granulopoietic development of hematopoietic cells. Blood. 2003; 102(9):3163-71. DOI: 10.1182/blood-2003-02-0479. View

Yeamans C, Wang D, Paz-Priel I, Torbett B, Tenen D, Friedman A . C/EBPalpha binds and activates the PU.1 distal enhancer to induce monocyte lineage commitment. Blood. 2007; 110(9):3136-42. PMC: 2200910. DOI: 10.1182/blood-2007-03-080291. View

Tenen D . Disruption of differentiation in human cancer: AML shows the way. Nat Rev Cancer. 2003; 3(2):89-101. DOI: 10.1038/nrc989. View

Leroy H, Roumier C, Huyghe P, Biggio V, Fenaux P, Preudhomme C . CEBPA point mutations in hematological malignancies. Leukemia. 2005; 19(3):329-34. DOI: 10.1038/sj.leu.2403614. View

Rodrigues N, Janzen V, Forkert R, Dombkowski D, Boyd A, Orkin S . Haploinsufficiency of GATA-2 perturbs adult hematopoietic stem-cell homeostasis. Blood. 2005; 106(2):477-84. DOI: 10.1182/blood-2004-08-2989. View

Emambokus N, Vegiopoulos A, Harman B, Jenkinson E, Anderson G, Frampton J . Progression through key stages of haemopoiesis is dependent on distinct threshold levels of c-Myb. EMBO J. 2003; 22(17):4478-88. PMC: 202376. DOI: 10.1093/emboj/cdg434. View

Armstrong S, Staunton J, Silverman L, Pieters R, den Boer M, Minden M . MLL translocations specify a distinct gene expression profile that distinguishes a unique leukemia. Nat Genet. 2001; 30(1):41-7. DOI: 10.1038/ng765. View

Golub T, Slonim D, Tamayo P, Huard C, Gaasenbeek M, Mesirov J . Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. Science. 1999; 286(5439):531-7. DOI: 10.1126/science.286.5439.531. View

10.

Charrad R, Gadhoum Z, Qi J, Glachant A, Allouche M, Jasmin C . Effects of anti-CD44 monoclonal antibodies on differentiation and apoptosis of human myeloid leukemia cell lines. Blood. 2002; 99(1):290-9. DOI: 10.1182/blood.v99.1.290. View

11.

Tavor S, Park D, Gery S, Vuong P, Gombart A, Koeffler H . Restoration of C/EBPalpha expression in a BCR-ABL+ cell line induces terminal granulocytic differentiation. J Biol Chem. 2003; 278(52):52651-9. DOI: 10.1074/jbc.M307077200. View

12.

Keeshan K, Santilli G, Corradini F, Perrotti D, Calabretta B . Transcription activation function of C/EBPalpha is required for induction of granulocytic differentiation. Blood. 2003; 102(4):1267-75. DOI: 10.1182/blood-2003-02-0477. View

13.

Edgar R, Domrachev M, Lash A . Gene Expression Omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Res. 2001; 30(1):207-10. PMC: 99122. DOI: 10.1093/nar/30.1.207. View

14.

Nicolaides N, Gualdi R, Casadevall C, Manzella L, Calabretta B . Positive autoregulation of c-myb expression via Myb binding sites in the 5' flanking region of the human c-myb gene. Mol Cell Biol. 1991; 11(12):6166-76. PMC: 361795. DOI: 10.1128/mcb.11.12.6166-6176.1991. View

15.

Gewirtz A, Calabretta B . A c-myb antisense oligodeoxynucleotide inhibits normal human hematopoiesis in vitro. Science. 1988; 242(4883):1303-6. DOI: 10.1126/science.2461588. View

16.

Iwama A, Zhang P, Darlington G, McKercher S, Maki R, Tenen D . Use of RDA analysis of knockout mice to identify myeloid genes regulated in vivo by PU.1 and C/EBPalpha. Nucleic Acids Res. 1998; 26(12):3034-43. PMC: 147647. DOI: 10.1093/nar/26.12.3034. View

17.

Corradini F, Cesi V, Bartella V, Pani E, Bussolari R, Candini O . Enhanced proliferative potential of hematopoietic cells expressing degradation-resistant c-Myb mutants. J Biol Chem. 2005; 280(34):30254-62. DOI: 10.1074/jbc.M504703200. View

18.

Zhang D, Hetherington C, Chen H, Tenen D . The macrophage transcription factor PU.1 directs tissue-specific expression of the macrophage colony-stimulating factor receptor. Mol Cell Biol. 1994; 14(1):373-81. PMC: 358386. DOI: 10.1128/mcb.14.1.373-381.1994. View

19.

Porse B, Pedersen TA , Xu X, Lindberg B, Wewer U, Friis-Hansen L . E2F repression by C/EBPalpha is required for adipogenesis and granulopoiesis in vivo. Cell. 2001; 107(2):247-58. DOI: 10.1016/s0092-8674(01)00516-5. View

20.

Chang J, Santhanam R, Trotta R, Neviani P, Eiring A, Briercheck E . High levels of the BCR/ABL oncoprotein are required for the MAPK-hnRNP-E2 dependent suppression of C/EBPalpha-driven myeloid differentiation. Blood. 2007; 110(3):994-1003. PMC: 1924762. DOI: 10.1182/blood-2007-03-078303. View